Prospective Cohort Study of the Effect of Bariatric/Metabolic Surgery on Morbid Obesity Patients With Metabolic Syndrome
NCT ID: NCT02271568
Last Updated: 2016-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2015-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Bariatric/Metabolic Surgery on GFR
NCT02406664
The Effect of Bariatric Surgery on Glucose Metabolism
NCT04174768
Metabolic Surgery for Metabolic Syndrome
NCT07183137
the Related Factors of Bariatric Surgery on Glomerular Filtration Rate
NCT03689777
Korean OBEsity Surgical Treatment Study
NCT03100292
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Obesity constitutes a strong risk factor for the development of chronic kidney disease. Among diabetics, obesity is known to amplify the risk for kidney disease.
Bariatric surgery has yielded dramatic results including longitudinal loss of excess body weight and either complete reversal or significant improvement of several features of metabolic syndrome. In addition, many observational studies have demonstrated significant reduction in proteinuria after bariatric surgery.
However, the changes in the component of cardiovascular problem among metabolic syndrome and changes in renal filtration function or progression to end stage kidney disease in morbidly obese patients after weight loss surgery have not been extensively studied. Therefore, our study mainly focus on glomerular filtration rate(GFR) with known relation to the renal function and 24 hours ambulatory blood pressure monitoring after intervention of gastric bypass or medical treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obese patients
15 Obese patients (BMI\>30) having one of comorbidity (type 2 diabetes, dyslipidemia, or hypertension) and morbid obese patients (BMI\>35) accepted for bariatric surgery.
Bariatric surgery
Laparoscopic or Robot R-Y gastric bypass
Control patients
15 matched controls receiving Intensive medical therapy
Intensive medical therapy
intensive medical therapy according to published guidelines by ADA and EASD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bariatric surgery
Laparoscopic or Robot R-Y gastric bypass
Intensive medical therapy
intensive medical therapy according to published guidelines by ADA and EASD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Morbid obese patients (BMI\>35)
Exclusion Criteria
* Malignancy (any type)
* End stage renal disease
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hanyang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tae Kyung Ha
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tae Kyung Ha, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Hanyang University Seoul Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Seoul Hospital
Seongdong-gu, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HYUH 2013-07-024-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.